Warning letter
Meridian Medical Technologies, Inc. a Pfizer Company: warning letter of Sep 5, 2017
FDA warning letter 525881 · Kansas City District Office
Key facts
| Reference number | 525881 |
|---|---|
| Company | Meridian Medical Technologies, Inc. a Pfizer Company |
| Subject | CGMP/QSR/Drug/Medical Devices/Adulterated |
| Issue date | Sep 5, 2017 |
| Posted date | Sep 5, 2017 |
| Issuing office | Kansas City District Office |
| Product type | Drugs |
| CFR sections cited | 211.192, 4, 820 |
| Inspection city | Saint Louis |
| Inspection ZIP | 63146 |
| Inspection start date | Feb 20, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: